THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 151 filers reported holding THERAVANCE INC in Q4 2013. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $666,000 | -67.4% | 92,765 | -17.9% | 0.04% | -46.9% |
| Q2 2015 | $2,042,000 | +14.5% | 112,990 | -0.4% | 0.08% | +72.3% |
| Q1 2015 | $1,783,000 | -22.4% | 113,401 | -30.1% | 0.05% | 0.0% |
| Q4 2014 | $2,297,000 | +4.0% | 162,324 | +25.6% | 0.05% | +51.6% |
| Q3 2014 | $2,208,000 | -73.7% | 129,221 | -54.2% | 0.03% | -68.4% |
| Q2 2014 | $8,395,000 | +2.7% | 281,885 | +6.7% | 0.10% | -16.9% |
| Q1 2014 | $8,173,000 | -64.8% | 264,141 | -56.7% | 0.12% | -17.5% |
| Q4 2013 | $23,250,000 | +95.4% | 609,535 | +109.4% | 0.14% | -13.3% |
| Q3 2013 | $11,899,000 | +32.4% | 291,143 | +24.8% | 0.16% | +42.2% |
| Q2 2013 | $8,986,000 | – | 233,222 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
| Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
| SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
| Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
| Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
| Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
| BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
| PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |